Stock Thread (21 Viewers)

[The General]

Would people buy some GD meatless burgers and help a brother out? BYND needs you.

 

[Don Hutson]

$6.03!  Someone on the boards said there was a massive buy of 250,000 shares.

 

[Chaz McNulty]

They’re as far into trials for Covid therapeutics as almost anyone. Their MOA makes sense, no?

What’s bearish? 

They were discussing the Cytokyn Storm atleast a month before anyone else.

 

[jamny]

Who has some cash...go buy some at 6 already.

Thank you!

 

[skycriesmary]

It’s about 9% of mine right now but half of that is profit. My cost is right is about 4%. I may trim end of day as it tends to pop lately close to the end of the day. I’m not sure if I can sell half and know that I’m free rolling because I’d hate to miss out on a huge gain but damn it would suck to make nothing on it at this point. 

Yeah, the prudent thing to do would be sell another 1/3 to make sure that if this does go up the creek that I won't end up losing my buy in on all my buying and selling of it. I feel like there's a 30-40-% chance for this to moon, 60-70% to crater. The thing that puts the fly into the ointment is my intuition on stocks is wrong about 80% of the time. 

 

[Capella]

$6.03!  Someone on the boards said there was a massive buy of 250,000 shares.

Guys I’m starting to think we are going to get rich. Are we going to get rich? 

 

[ChiefD]

Guys I’m starting to think we are going to get rich. Are we going to get rich? 

I'm not because I got in late. I'm just hopeful to learns some things and make a little money if possible. Either way I'm holding.

 

[Don Hutson]

$6.13!  The melt up has begun!

 

[BassNBrew]

$6.13!  The melt up has begun!

Now falling

 

[Don Hutson]

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157023909

Newly announced CytoDyn Scientific Advisory Board member Dr. Hope S. Rugo will be featured on Research To Practice tonight:

Recent Advances in Medical Oncology:
Focus on Triple-Negative Breast Cancer
Part 6 of a 14-Part CME Webinar Series Held in
Conjunction with ASCO20 Virtual
Monday, July 20 — 5:00 PM - 6:00 PM ET
Access Tonight's Webinar: https://us02web.zoom.us/webinar/register/WN_olnKrJvGQg2eBvm0prFz7w
Our summer webinar series held in partnership with the American Society of Clinical Oncology continues tonight at 5 PM ET as Drs Joyce O’Shaughnessy and Hope S Rugo join me to share their perspectives on optimal targeted treatment approaches for patients with triple-negative breast cancer and touch on how the COVID-19 pandemic has affected the delivery of cancer care.///

 

[Capella]

Boy these last 15 minutes today are going to be wild 

 

[Don Hutson]

Now falling

Happens with all melt ups.  Two steps forward, one step back.  I think we end at $6.50+ today.

 

[BassNBrew]

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157023909

Newly announced CytoDyn Scientific Advisory Board member Dr. Hope S. Rugo will be featured on Research To Practice tonight:

Recent Advances in Medical Oncology:
Focus on Triple-Negative Breast Cancer
Part 6 of a 14-Part CME Webinar Series Held in
Conjunction with ASCO20 Virtual
Monday, July 20 — 5:00 PM - 6:00 PM ET
Access Tonight's Webinar: https://us02web.zoom.us/webinar/register/WN_olnKrJvGQg2eBvm0prFz7w
Our summer webinar series held in partnership with the American Society of Clinical Oncology continues tonight at 5 PM ET as Drs Joyce O’Shaughnessy and Hope S Rugo join me to share their perspectives on optimal targeted treatment approaches for patients with triple-negative breast cancer and touch on how the COVID-19 pandemic has affected the delivery of cancer care.///

Not good IMO.

 

[dkp993]

@chet has been awful silent on here the past week or so.  Not saying that means good or bad news, it just out of the ordinary. 

 

[dkp993]

Not good IMO.

Why?

 

[Chaz McNulty]

I mistimed this.  Got in at $6.10.  Hopefull it can get to $6.50 by eod.

 

[⚡DEADHEAD⚡]

Not good IMO.

It is curious to say the least.

 

[Capella]

It is curious to say the least.

What am I missing here? That she is discussing cancer and not corona? Maybe that’s just her lane. 

 

[Jayrok]

Why?

Agree.  It's not related to Covid or the Covid trial data.  It's focusing on triple-negative breast cancer and some how Covid has distracted focus from cancer care.  It's good for down the road indication of cancer.  

 

[BassNBrew]

Why?

Why would you be pimping an alternate use on the day or day before your COVID release?  This appears like the COVID data was the suck and they are moving on to the next shiny thing.

 

[Moonlight]

cydy jumping now.

 

[Jayrok]

What am I missing here? That she is discussing cancer and not corona? Maybe that’s just her lane. 

Correct.  And newly appointed.  She may not even be involved with the Covid related research. 

 

[⚡DEADHEAD⚡]

Why would you be pimping an alternate use on the day or day before your COVID release?  This appears like the COVID data was the suck and they are moving on to the next shiny thing.

Right.

 

[fantasycurse42]

Why would you be pimping an alternate use on the day or day before your COVID release?  This appears like the COVID data was the suck and they are moving on to the next shiny thing.

Agree, why discuss cancer when your Covid results are front and center?

 

[Jayrok]

Why would you be pimping an alternate use on the day or day before your COVID release?  This appears like the COVID data was the suck and they are moving on to the next shiny thing.

It was already scheduled as part of a 14 part series.  

 

[BassNBrew]

What am I missing here? That she is discussing cancer and not corona? Maybe that’s just her lane. 

This would be like Santa pulling all the kids aside on December 24th to discuss how fat the the turkeys are looking for next year.

 

[Capella]

Hope S. Rugo, MD, FASCO, is professor of medicine in the Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, where she is also the director of Breast Oncology and Clinical Trials Education.
 

it’s just her field of focus gang. 

 

[Jayrok]

Agree, why discuss cancer when your Covid results are front and center?

covid-19 isn't their only area of focus.  I don't see this as bad at all.  

 

[Capella]

I get we’re all paranoid but this is stretching the boundaries of it lol 

 

[Moonlight]

Opportunity to discuss application of leronlimab to breast cancer.

 

[Jayrok]

Paranoia abounds in here sometimes.  

 

[Capella]

This would be like Santa pulling all the kids aside on December 24th to discuss how fat the the turkeys are looking for next year.

Not if there were 7 Santas though and one of them was focused on fat turkeys. 

 

[⚡DEADHEAD⚡]

Force multiplier maybe? That's the bright side anyway.

If indeed scheduled a long time ago, all good. Canceling would be more ominous.

 

[The Ref]

I get we’re all paranoid but this is stretching the boundaries of it lol 

This.  Everyone take a deep breath..... unless you have corona.... which this is going to help with.

 

[fantasycurse42]

covid-19 isn't their only area of focus.  I don't see this as bad at all.  

If their Covid results are the suck, our investment falls at a minimum 50%, maybe upwards of 80-90%.

That’s the bottom line. 

 

[dkp993]

Why would you be pimping an alternate use on the day or day before your COVID release?  This appears like the COVID data was the suck and they are moving on to the next shiny thing.

I’m not sure I agree. Cancer and HIV was always the main driver of the company. Covid is the recent development. But they should still be focused on what was always the long-term goal.  

 

[fantasycurse42]

It was already scheduled as part of a 14 part series.  

If it was scheduled in advance, I’m okay with it. 

 

[ex-ghost]

Power Hour time. CYDY at $6.35. Decent run up.

 

[Don Hutson]

$6.39

 

[dkp993]

Agree, why discuss cancer when your Covid results are front and center?

Because it is and always was the focus of this drug.  

 

[Jayrok]

If their Covid results are the suck, our investment falls at a minimum 50%, maybe upwards of 80-90%.

That’s the bottom line. 

Well sure.  I get that.  But this webinar was already scheduled and she has nothing to do with the covid trials or the data.  Non sequitur.

 

[djmich]

poppity poppin

 

[JetMaxx]

I’m not sure I agree. Cancer and HIV was always the main driver of the company. Covid is the recent development. But they should still be focused on what was always the long-term goal.  

I thought we covered this. It cures erectile dysfunction, male pattern baldness and grumpy wife syndrome

 

[Capella]

Omgggggggggg

 

[Don Hutson]

$6.69.  Nice.

 

[Jayrok]

I actually wish something was leaked to someone and they're loading up.   Waiting for a PR is overrated.  

 

[The Ref]

$6.68, $4.68, $8.68

it doesn’t matter unless you are selling 

 

[ghostguy123]

Short squeeze?

 

[The Ref]

Apparently there was a big buy of 250K shares

 

[JetMaxx]

I won’t net a Lambo or yacht but I will name the new 35’s on my truck the @chet thread tread